MRNA – moderna, inc. (US:NASDAQ)

News

Moderna, Inc. (MRNA) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]
Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Berenberg Bank. They set a "hold" rating and a $42.00 price target on the stock.
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Moderna, Inc. (NASDAQ: MRNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $69.00 price target on the stock, down previously from $115.00.
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com